Rising Addiction Linked To Smoking Fuels Growth In Quit-Smoking Drug Market: Critical Driver Shaping the Quit Smoking Drugs Market in 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Quit Smoking Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for drugs that help quit smoking has seen fast-paced expansion in the recent past. The market, which stood at $39.26 billion in 2024, is predicted to balloon up to $44.62 billion in 2025, boasting a compound annual growth rate (CAGR) of 13.7%. This surge in the historical timeframe is due to several factors including health consciousness campaigns, advancements in the medical field, government-driven initiatives, the incorporation of behavioral therapies, and changes in consumer attitudes.

Quit Smoking Drugs Market Size Forecast: What's the Projected Valuation by 2029?
Expectations are high for significant expansion in the quit smoking drugs market in the upcoming years. The market is predicted to reach a value of $79.99 billion by 2029, with a compound annual growth rate (CAGR) of 15.7%. Several factors such as investments in research and development, the escalating demand for cessation aids, targeted marketing and awareness initiatives, and progress in pharmacotherapy are attributing to this growth during the forecast period. Notable trends in this period encompass individualized treatment methods, rising health consciousness, the emergence of digital therapeutics and apps, incorporation of behavioral therapy, and targeted education and marketing initiatives.

View the full report here:
https://www.thebusinessresearchcompany.com/report/quit-smoking-drugs-global-market-report

What Are the Drivers Transforming the Quit Smoking Drugs Market?
The escalating incidence of smoking addiction is anticipated to fuel the expansion of the market for quit-smoking drugs in the future. Smoking involves the inhalation and exhalation of vapors from burning substances like marijuana, hashish, tobacco, and more. Quit-smoking medications aim to limit the desire for smoking by suppressing the craving for tobacco in a person. These drugs serve as prescribed treatments to manage nicotine withdrawal symptoms, thereby supporting successful smoking cessation. For example, in July 2022, as per Statistics Canada, a governmental organization of Canada, there was a 5.8% rise in cigarette production compared to June 2021. Additionally, the total count of cigarettes sold climbed by 1.3% from May 2022, hitting 1.4 billion in June 2022. Thus, the steadily mounting incidence of smoking addiction is bolstering the growth of the quit-smoking drug market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9247&type=smp

What Long-Term Trends Will Define the Future of the Quit Smoking Drugs Market?
The role of product innovation in enhancing popularity is a trending factor in the quit smoking drugs market. To solidify their market standing, leading companies are focusing on bringing new and innovative products to the market. For instance, the Sweden-based firm, Swedish Match AB, introduced its product, ZYN Tobacco Gold, a tobacco flavored nicotine pouch, into travel retail in August 2022. These pouches, offered in medium (3 mg) and strong (6 mg) strengths, serve to fulfil consumer preferences with their sweet tobacco taste that brings to mind dried fruit, wood, and caramel. This flavor is currently the most preferred one for consumers seeking less hazardous alternatives that area also free of tobacco and smoke. These pouches thus serve as solutions for those wishing to avoid tobacco use while still enjoying a nicotine rush in smoke-free settings.

Which Segments in the Quit Smoking Drugs Market Offer the Most Profit Potential?
The quit smoking drugs market covered in this report is segmented -

1) By Product: Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets
2) By Drug: Varenicline (Chantix), Bupropion (Zyban), Other Drugs
3) By Distribution: Drug Store, Online Pharmacies, Retail Pharmacies

Subsegments:
1) By Drug Therapy: Bupropion (Zyban), Varenicline (Chantix)
2) By E-Cigarettes: Disposable E-Cigarettes, Rechargeable E-Cigarettes, Pod Systems
3) By Nicotine Inhalers: Prescription Inhalers, Over-The-Counter Inhalers
4) By Nicotine Replacement Therapies (NRT): Nicotine Patches, Nicotine Gum, Nicotine Lozenges
5) By Nicotine Sublingual Tablets: Fast-Acting Sublingual Tablets, Extended-Release Sublingual Tablets

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9247&type=smp

Which Firms Dominate the Quit Smoking Drugs Market by Market Share and Revenue in 2025?
Major companies operating in the quit smoking drugs market include 22nd Century Group, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Novartis AG, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, Rusan Pharma Ltd., BioCorRx Inc., CV Sciences Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Gilla Inc., Hikma Pharmaceuticals PLC, Innovus Pharmaceuticals Inc., IntelGenx Technologies Corp.

Which Regions Offer the Highest Growth Potential in the Quit Smoking Drugs Market?
North America was the largest region in the quit smoking drugs market in 2024. The regions covered in the quit smoking drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9247

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.